American International Group, Inc. Ampio Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.16 - $0.47 $15,477 - $45,466	-96,737 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.42 - $0.62 $2,859 - $4,220	-6,808 Reduced 6.57%	96,737 $45,000
Q4 2021 Feb 11, 2022	SELL	$0.56 - $1.71 $1,735 - $5,299	-3,099 Reduced 2.91%	103,545 $59,000
Q3 2021 Nov 12, 2021	BUY	$1.21 - $1.8 $76 - $113	63 Added 0.06%	106,644 $177,000
Q2 2021 Aug 13, 2021	BUY	$1.56 - $1.98 $166,266 - $211,030	106,581 New	106,581 $178,000
Q2 2019 Aug 13, 2019	SELL	$0.39 - $0.7 $24,346 - $43,698	-62,427 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$0.43 - $0.68 $869 - $1,375	-2,023 Reduced 3.14%	62,427 $35,000
Q4 2018 Feb 13, 2019	SELL	$0.39 - $0.7 $193 - $347	-497 Reduced 0.77%	64,450 $25,000
Q3 2018 Nov 09, 2018	BUY	$0.44 - $3.02 $5,841 - $40,093	13,276 Added 25.69%	64,947 $33,000
Q2 2018 Aug 08, 2018	BUY	$1.66 - $3.82 $85,773 - $197,383	51,671 New	51,671 $114,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.